Imprimis Pharmaceuticals, Inc.
(NASDAQ : IMMY)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Loading IMMY News...
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SHPGShire PLC Sponsored ADR
-0.50%176.960.4%$170.90m
PRGOPerrigo Co. Plc
-0.03%73.996.4%$144.57m
VRXValeant Pharmaceuticals International, Inc.
-1.39%9.2514.2%$140.56m
ALRAlere Inc.
0.12%49.162.7%$137.07m
UTHRUnited Therapeutics Corporation
4.32%125.7013.9%$97.54m
JAZZJazz Pharmaceuticals Plc
-1.69%159.282.2%$89.92m
MDCOMedicines Company
1.52%49.3222.5%$75.86m
ENDPEndo International Plc
0.80%11.378.9%$73.90m
MNKMallinckrodt Plc
1.16%46.9216.8%$69.52m
HZNPHorizon Pharma plc
-0.71%15.387.6%$41.04m
ICLRICON Plc
1.59%84.494.1%$35.05m
ICPTIntercept Pharmaceuticals, Inc.
-0.78%112.3522.3%$34.59m
PRXLPAREXEL International Corporation
0.73%63.837.9%$33.77m
PCRXPacira Pharmaceuticals, Inc.
1.04%48.5510.9%$31.50m
GWPHGW Pharmaceuticals PLC Sponsored ADR
0.25%118.737.6%$28.29m

Company Profile

Imprimis Pharmaceuticals, Inc. engages in the development, production, and dispensing of innovative proprietary compounded pharmaceuticals. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in San Diego, CA.